Insilico Medicine is an artificial intelligence company located at the Emerging Technology Centers at the Johns Hopkins University Eastern campus in Baltimore, with R&D resources in 6 countries sourced through hackathons and competitions. The company specializes in the generative adversarial networks and reinforcement learning for drug discovery for age-related diseases with a pipeline of over one thousand high-value pre-clinical leads. Through its Pharma.AI division, Insilico provides the next-generation AI solutions to biotechnology, pharmaceutical, and skin care companies, foundations and national governments globally. In 2017, NVIDIA selected Insilico Medicine as one of the Top 5 AI social impact companies. The company is strongly committed to reducing or eliminating AI and human biases and openly exposes the challenges posed by AI in the healthcare industry.

Visit website

Partners & Attendees

Acc1.001
Mit tech review.001
Svb.001
Facebook.001
Forbes.001
Applause .001
Twentybn.001
Logo resizing for re%e2%80%a2work website %2823%29
Intel21.001
Logo resizing for re%e2%80%a2work website %2824%29
Seldon
Rasalogo.001
This website uses cookies to ensure you get the best experience. Learn more